Filing Details

Accession Number:
0000905148-25-001866
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-20 16:59:06
Reporting Period:
2025-05-16
Filing Date:
2025-05-20
Accepted Time:
2025-05-20 16:59:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604464 Atara Biotherapeutics Inc. ATRA ()
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2064348 Yanina Grant-Huerta C/O Atara Biotherapeutics, Inc.
1280 Rancho Conejo Boulevard
Thousand Oaks CA 91320
Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-05-16 2,218 $6.76 37,067 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
  2. The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2025 and May 19, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.